Skip to search formSkip to main contentSkip to account menu

emeriamine

Known as: 3-amino-4-trimethylaminobutyric acid, amino-carnitine, aminocarnitine 
National Institutes of Health

Related topics

Related topics

5 relations

Broader (4)

BetaineCarnitineEnzyme InhibitorsHypoglycemic Agents
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2003
Highly Cited
2003
Discovery of a long-chain carbamoyl aminocarnitine derivative, a reversible carnitine palmitoyltransferase inhibitor with antiketotic and antidiabetic activity.
The synthesis and pharmacological activity of reversible CPT I inhibitors as potential antiketotic and antidiabetic drugs are… 
Review
2002
Review
2002
The Use of Partial Fatty Acid Oxidation Inhibitors for Metabolic Therapy of Angina Pectoris and Heart Failure
Background: Partial fatty acid oxidation inhibitors have raised great interest since they are expected to counteract a… 
1997
1997
The use of cis-parinaric acid to measure lipid peroxidation in cardiomyocytes during ischemia and reperfusion.
1992
1992
Carnitine requirement of vascular endothelial and smooth muscle cells in imminent ischemia
Vascular endothelial and -smooth muscle cells have been shown to use fatty acids as substrates for oxidative phosphorylation… 
1991
1991
Effect of clofibrate treatment on hepatic prostaglandin catabolism and action.
Prostaglandins (PG) modulate hepatocyte glucose and lipid metabolism. Hepatocytes rapidly metabolize PG via beta-oxidation… 
1989
1989
Effect of L-carnitine and L-aminocarnitine on calcium transport, motility, and enzyme release from ejaculated bovine spermatozoa.
Experiments were performed to further elucidate the role of gamma-amino-beta-hydroxybutyric acid trimethylbetaine (carnitine) on… 
Review
1987
Review
1987
Inhibitors of fatty acid oxidation.
Highly Cited
1987
Highly Cited
1987
Chemistry and inhibitory activity of long chain fatty acid oxidation of emeriamine and its analogues.
Emericedins A, B, and C, new betaines having inhibitory activity of long chain fatty acid oxidation, were isolated from the… 
1986
1986
Antiketogenic and hypoglycemic effects of aminocarnitine and acylaminocarnitines.
DL-Aminocarnitine (DL-3-amino-4-trimethylaminobutyrate) is a potent, noncovalent inhibitor of carnitine palmitoyltransferase… 
1985
1985
DL-aminocarnitine and acetyl-DL-aminocarnitine. Potent inhibitors of carnitine acyltransferases and hepatic triglyceride catabolism.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)